# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA672139 | F | Concentration required to cause a microscopically detectable alteration of normal cell morphology in E6SM cells | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
2. | ALA672140 | F | Concentration required to inhibit HSV-1 (F) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
3. | ALA671311 | F | Concentration required to inhibit HSV-1 (KOS) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
4. | ALA671312 | F | Concentration required to inhibit HSV-1 (McIntyre) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
5. | ALA671314 | F | Concentration required to inhibit HSV-2(196) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
6. | ALA674354 | F | Concentration required to inhibit HSV-2(G) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
7. | ALA674355 | F | Concentration required to inhibit HSV-2(lyons) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
8. | ALA674356 | F | Concentration required to inhibit TK-HSV-1 (B2006) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
9. | ALA674357 | F | Concentration required to inhibit TK-HSV-1 (VMW1837) induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
10. | ALA857932 | F | Concentration required to inhibit VSV induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
11. | ALA677330 | F | oncentration required to inhibit VV induced cytopathogenicity in E6SM cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
12. | ALA687471 | F | Concentration required to cause 50% reduction in HEL cell growth. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
13. | ALA857200 | F | Concentration required to inhibit CMV (AD-169) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
14. | ALA687475 | F | Concentration required to inhibit CMV (Davis) induced cytopathogenicity in HEL cells by 50%; ND = not determined | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
15. | ALA687477 | F | Concentration required to inhibit TK-VZV (07-1) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
16. | ALA687630 | F | Concentration required to inhibit TK-VZV (YSR) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
17. | ALA692682 | F | Concentration required to inhibit VZV (YS) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
18. | ALA692684 | F | Concentration required to inhibit VZV (oka) induced cytopathogenicity in HEL cells by 50%. | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
19. | ALA816092 | B | Binding affinity towards HSV-1 thymidine kinase | 18 | single protein format | Scientific Literature |